Role of vascular endothelial growth factor in women with PCO and PCOS: A systematic review

Reproductive BioMedicine Online

Volumn 20, Issue 4, 2010, Pages 444-452

  Peitsidis, Panagiotis ^a   Agrawal, Rina ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

OHSS; PCO; PCOS; VEGF

Indexed keywords

CYTOKINE; GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

BIOAVAILABILITY; CINAHL; CIRCULATION; COCHRANE LIBRARY; CULTURE MEDIUM; EMBASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LABORATORY TEST; LUTEAL CELL; MEDLINE; NONHUMAN; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REPRODUCTIVE PROCEDURES; REVIEW; SYSTEMATIC REVIEW;

EID: 77951652524     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.01.007     Document Type: Review

References (47)

1. Abd El Aal, D.E., Mohamed, S.A., Amine, A.F., et al., 2005. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur. J. Obstet. Gynecol. Reprod. Biol. 1, 219-224.
2. Aboulghar, M.A., Mansour, R.T., Serour, G.I., et al., 1992. Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. J. Assist. Reprod. Genet. 9, 238-243.
3. Abramov, Y., Barak, V., Nisman, B., Schenker, J.G., 1997. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril. 67, 261-265.
4. Agrawal, R., Conway, G., Sladkevicius, P., et al., 1998a. Serum vascular endothelial growth factor and Doppler blood flow velocities in in-vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil. Steril. 70, 651-658.
5. Agrawal, R., Jacobs, H., Payne, N., Conway, G., 2002. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil. Steril. 78, 1164-1169.
6. Agrawal, R., Sladkevicius, P., Engmann, L., et al., 1998b. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum. Reprod. 13, 651-655.
7. Aleem, F.A., Predanic, M., 1996. Transvaginal colour Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil. Steril. 65, 510-516.
8. Amin, A.F., Abd el-Aal, D.E., Darwish, A.M., Meki, A.R., 2003. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome. Fertil. Steril. 79, 938-941.
9. Artini, P.G., Fasciani, A., Monti, M., et al., 1998. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation in women enrolled in an in-vitro fertilization program. Fertil. Steril. 70, 560-564.
10. Artini, P.G., Monti, M., Matteucci, C., et al., 2006. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol. Endocrinol. 22, 465-470.
11. Artini, P.G., Ruggiero, M., Parisen Toldin, M.R., et al., 2009a. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum. Fertil. (Camb.) 12, 40-44.
12. Artini, P.G., Ruggiero, M., Parisen Toldin, M.R., Monteleone, P., Monti, M., Cela, V., Genazzani, A.R., 2009b. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum. Fertil. (Camb.) 12(1), 40-44.
13. Babayof, R., Margalioth, E.J., Huleihel, M., et al., 2006. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum. Reprod. 21, 1260-1265.
14. Balen, A., 2005. Ovarian hyperstimulation syndrome - a short report for the HFEA.
15. Battaglia, C., Artini, P.G., D'Ambrogio, G., et al., 1995. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am. J. Obstet. Gynecol. 172, 108-113.
16. Bider, D., Menashe, Y., Oelsner, G., et al., 1989. Ovarian hyperstimulation due to exogenous gonadotropin administration. Acta Obstet. Gynecol. Scand. 69, 511-514.
17. Bokal, E.V., Virant Klun, I., Verdenik, I., 2009. Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Reprod. Biomed. Online 18 (1), 21-28.
18. Bokal, E.V., Vrtovec, H.M., Virant Klun, I., Verdenik, I., 2005. Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome. Hum. Reprod. 20, 1562-1568.
19. Charbonnel, B., Krempf, M., Blanchard, P., et al., 1987. Induction of ovulation in polycystic ovary syndrome with a combination of luteinizing hormone releasing hormone analogue and exogenous gonadotropins. Fertil. Steril. 47, 920-924.
20. Delvigne, A., Demoulin, A., Smitz, J., et al., 1993a. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicenter study. I. Clinical and biological features. Hum. Reprod. 8, 1353-1360.
21. Delvigne, A., Dubois, M., Battheu, B., et al., 1993b. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicenter study. II. Multiple discriminant analysis for risk prediction. Hum. Reprod. 8, 1361-1366.
22. Ferrara, N., 2005. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS. (94), 209-231.
23. Ferrara, N., Davis-Smyth, T., 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25.
24. Ferrara, N., Frantz, G., LeCouter, J., et al., 2003. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am. J. Pathol. 162(6), 1881-1893.
25. Friedman, C.l., Seifer, D.B., Kennard, E.A., et al., 1998. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil. Steril. 70, 836-839.
26. García-Velasco, J.A., Pellicer, A., 2003. New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr. Opin. Obstet. Gynecol. 15, 251-256.
27. Geva, E., Jaffe, R.B., 2002. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril. 74, 429-438.
28. Holmes, D.I., Zachary, I., 2005. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 6 (2), 209. (Pubitemid 40352680)
29. Kamat, B.R., Brown, L.F., Manseau, E.J., Senger, D.R., Dvorak, H.F., 1995. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 146 (1), 157-165.
30. Krasnow, J.S., Berga, S.L., Guzick, D.S., Zeleznik, A.J., Yeo, K.T., 1996. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril. 65, 552-555.
31. Lee, E.J., Oh, B., Lee, J.Y., et al., 2008. Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome. Fertil. Steril. 89, 1751-1759.
32. Levin, E.R., Rosen, G.F., Cassidenti, D.L., et al., 1998. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J. Clin. Invest. 102 (11), 1978-1985.
33. MacDougall, M.J., Tan, S.L., Jacobs, H.S., 1992. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 7 (5), 597-600.
34. MacDougall, J.M., Tan, S.L., Balen, A.H., et al., 1993. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod. 8, 233-237.
35. Malamitsi-Puchner, A., Sarandakou, A., Baka, S.G., et al., 2001. Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity and fertilization. Fertil. Steril. 76 (1), 98-101.
36. McClure, N., Healy, D.L., Rogers, P.A., et al., 1994. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344, 235-2243.
37. Meldrum, D.R., 2002. Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil. Steril. 78, 1170-1171.
38. Neulen, J., Raczek, S., Pogorzelski, M., et al., 1998. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol. Hum. Reprod. 4, 203-206.
39. Ng, E.H., Chan, C.C., Yeung, W.S., Ho, P.C., 2005. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome. Hum. Reprod. 7, 1881-1886.
40. Rizk, B., Aboulghar, M., 1991. Modern management of ovarian hyperstimulation syndrome. Hum. Reprod. 6 (8), 1082-1087.
41. Schenker, J.G., Weinstein, D., 1978. Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril. 30, 255-268.
42. Smitz, J., Camus, M., Devroey, P., et al., 1990. Incidence of severe ovarian hyperstimulation syndrome after GnRH-agonist/HMG superovulation for in-vitro fertilization. Hum. Reprod. 5, 933-937.
43. Stanek, M.B., Borman, S.M., Molskness, T.A., et al., 2007. Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women. J. Clin. Endocrinol. Metab. 92, 2726-2733.
44. Tamanini, C., De Ambrogi, M., 2004. Angiogenesis in developing follicle and corpus luteum. Reprod. Domest. Anim. 39, 206-216.
45. Tulandi, T., Saleh, A., Morris, D., et al., 2000. Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome. Fertil. Steril. 74, 585-588.
46. Van Blerkom, J., Antczak, M., Schrander, R., 1997. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum. Reprod. 12, 1047-1055.
47. Zaidi, J., Campbell, S., Pitroff, R., et al., 1995. Ovarian stromal blood flow in women with polycystic ovaries a possible new marker for diagnosis? Hum. Reprod. 10, 1992-1996.